Your browser doesn't support javascript.
loading
Post-diagnostic health behaviour scores and risk of prostate cancer progression and mortality.
Langlais, Crystal S; Graff, Rebecca E; Van Blarigan, Erin L; Neuhaus, John M; Cowan, Janet E; Broering, Jeanette M; Carroll, Peter; Kenfield, Stacey A; Chan, June M.
Afiliación
  • Langlais CS; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA. crystal.langlais@ucsf.edu.
  • Graff RE; IQVIA, Durham, NC, USA. crystal.langlais@ucsf.edu.
  • Van Blarigan EL; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
  • Neuhaus JM; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
  • Cowan JE; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
  • Broering JM; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
  • Carroll P; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.
  • Kenfield SA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
  • Chan JM; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.
Br J Cancer ; 129(2): 346-355, 2023 08.
Article en En | MEDLINE | ID: mdl-37217583
ABSTRACT

BACKGROUND:

Individual behaviours are associated with prostate cancer (PC) progression. Behavioural scores, comprised of multiple risk factors, allow assessment of the combined impact of multiple behaviours.

METHODS:

We examined the association between six a priori scores and risk of PC progression and mortality among 2156 men with PC in the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) cohort two scores developed based on the PC survivorship literature ('2021 Score [+ Diet]'); a score developed based on pre-diagnostic PC literature ('2015 Score'); and three scores based on US recommendations for cancer prevention ('WCRF/AICR Score') and survival ('ACS Score [+ Alcohol]'). Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated for progression and PC mortality via parametric survival models (interval censoring) and Cox models, respectively.

RESULTS:

Over a median (IQR) of 6.4 (1.3, 13.7) years, we observed 192 progression and 73 PC mortality events. Higher (i.e., healthier) 2021 Score + Diet and WCRF/AICR Scores were inversely associated with risk of PC progression (2021 + Diet HRcontinuous = 0.76, 95% CI 0.63-0.90. WCRF/AICR HRcontinuous = 0.83, 95% CI 0.67-1.02) and mortality (2021 + Diet HRcontinuous = 0.65, 95% CI 0.45-0.93. WCRF/AICR HRcontinuous = 0.71; 95% CI 0.57-0.89). The ACS Score + Alcohol was only associated with progression (HRcontinuous = 0.89, 95% CI 0.81-0.98) while the 2021 Score was only associated with PC mortality (HRcontinuous = 0.62, 95% CI 0.45-0.85). The 2015 was not associated with PC progression or mortality.

CONCLUSION:

Findings strengthen the evidence that behavioural modifications following a prostate cancer diagnosis may improve clinical outcomes.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Br J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Br J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos